GlyR β Antibodies

Santa Cruz Biotechnology offers a broad range of GlyR β monoclonal antibodies for research focused on glycine receptor signaling. GlyR β Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GlyR β, a subunit of the glycine receptor, plays a crucial role in mediating inhibitory neurotransmission in the central nervous system. Its proper functioning is essential for maintaining the balance between excitatory and inhibitory signals, which is vital for normal motor control and sensory processing. Dysregulation of GlyR β has been implicated in various neurological disorders, making it an important target for research. Understanding GlyR β function can provide valuable insights into potential therapeutic approaches for neurological conditions. Research into GlyR β signaling pathways continues to reveal new aspects of neurotransmission regulation. Investigating GlyR β interactions with other proteins helps illuminate complex neurological processes. Santa Cruz Biotechnology monoclonal antibodies for GlyR β enable researchers worldwide to advance neuroscience and contribute to the development of new therapeutic strategies.